Home > > > > > Report Detail

Iron Deficiency Anemia - Epidemiology Forecast to 2028

Publisher Name :
Date: 15-Jan-2019
No. of pages: 50
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Iron Deficiency Anemia - Epidemiology Forecast, 2028" report provides a comprehensive analysis of the Iron Deficiency Anemia epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered

- United States

- EU5 (Germany, France, Italy, Spain, and the United Kingdom)

- Japan

Study Period: 2016-2028

Iron Deficiency Anemia Epidemiology

The epidemiology section covers the historical, current as well as forecasted epidemiology for Iron Deficiency Anemia in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders' views are also taken into account to provide a deep understanding of the Iron Deficiency Anemia outlook. It also includes the explanation of changing trends of epidemiology outlining the Iron Deficiency Anemia scenario.

Iron Deficiency Anemia Epidemiology Segmentation

The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Iron Deficiency Anemia thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope

- The report covers detailed overview of Iron Deficiency Anemia explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns

- It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan

- The Iron Deficiency Anemia Report assesses the disease risk and burden and highlights the unmet needs

- It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths

- 10 Year Forecast

- 7MM Coverage

- Total Cases in Iron Deficiency Anemia

Key assessments

- Patient Segmentation in Iron Deficiency Anemia

- Iron Deficiency Anemia Risk & Burden

- Factors driving growth in a specific Iron Deficiency Anemia patient population

Iron Deficiency Anemia - Epidemiology Forecast to 2028

Table of Contents

1. Report Introduction
2. Iron Deficiency Anemia Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Iron Deficiency Anemia in 2016
2.2. Patient Share Distribution of Iron Deficiency Anemia in 2028
3. Disease Background and Overview: Iron Deficiency Anemia
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Iron Deficiency Anemia in 7MM
4.3. Total Prevalent/ Incident Patient Population of Iron Deficiency Anemia in 7MM - By Countries
5. Epidemiology of Iron Deficiency Anemia by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Iron Deficiency Anemia
5.1.3. Sub-Type Specific cases of the Iron Deficiency Anemia *
5.1.4. Sex- Specific Cases of the Iron Deficiency Anemia *
5.1.5. Diagnosed Cases of the Iron Deficiency Anemia
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Iron Deficiency Anemia
5.4.3. Sub-Type Specific cases of the Iron Deficiency Anemia *
5.4.4. Sex- Specific Cases of the Iron Deficiency Anemia *
5.4.5. Diagnosed Cases of the Iron Deficiency Anemia
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Iron Deficiency Anemia
5.5.3. Sub-Type Specific cases of the Iron Deficiency Anemia *
5.5.4. Sex- Specific Cases of the Iron Deficiency Anemia *
5.5.5. Diagnosed Cases of the Iron Deficiency Anemia
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Iron Deficiency Anemia
5.6.3. Sub-Type Specific cases of the Iron Deficiency Anemia *
5.6.4. Sex- Specific Cases of the Iron Deficiency Anemia *
5.6.5. Diagnosed Cases of the Iron Deficiency Anemia
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Iron Deficiency Anemia
5.7.3. Sub-Type Specific cases of the Iron Deficiency Anemia *
5.7.4. Sex- Specific Cases of the Iron Deficiency Anemia *
5.7.5. Diagnosed Cases of the Iron Deficiency Anemia
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Iron Deficiency Anemia
5.8.3. Sub-Type Specific cases of the Iron Deficiency Anemia *
5.8.4. Sex- Specific Cases of the Iron Deficiency Anemia *
5.8.5. Diagnosed Cases of the Iron Deficiency Anemia
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Iron Deficiency Anemia
5.9.3. Sub-Type Specific cases of the Iron Deficiency Anemia *
5.9.4. Sex- Specific Cases of the Iron Deficiency Anemia *
5.9.5. Diagnosed Cases of the Iron Deficiency Anemia
6. Unmet Needs of the Iron Deficiency Anemia
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List of Tables

Table 1: Total Prevalent/Incident Cases of the Iron Deficiency Anemia in 7MM
Table 2: Total Prevalent/Incident Cases of the Iron Deficiency Anemia in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Iron Deficiency Anemia in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Iron Deficiency Anemia in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Iron Deficiency Anemia in United States (2016-2028)*
Table 6: Diagnosed Cases of the Iron Deficiency Anemia in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Iron Deficiency Anemia in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Iron Deficiency Anemia in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Iron Deficiency Anemia in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Iron Deficiency Anemia in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Iron Deficiency Anemia in France (2016-2028)
Table 12: Sub-Type Specific cases of the Iron Deficiency Anemia in France (2016-2028) *
Table 13: Sex- Specific Cases of the Iron Deficiency Anemia in France (2016-2028) *
Table 14: Diagnosed Cases of the Iron Deficiency Anemia in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Iron Deficiency Anemia in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Iron Deficiency Anemia in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Iron Deficiency Anemia in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Iron Deficiency Anemia in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Iron Deficiency Anemia in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Iron Deficiency Anemia in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Iron Deficiency Anemia in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Iron Deficiency Anemia in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Iron Deficiency Anemia in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Iron Deficiency Anemia in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Iron Deficiency Anemia in UK (2016-2028) *
Table 26: Diagnosed Cases of the Iron Deficiency Anemia in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Iron Deficiency Anemia in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Iron Deficiency Anemia in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Iron Deficiency Anemia in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Iron Deficiency Anemia in Japan (2016-2028)

List of Figures

Figure 1: Total Prevalent/Incident Cases of the Iron Deficiency Anemia in 7MM
Figure 2: Total Prevalent/Incident Cases of the Iron Deficiency Anemia in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Iron Deficiency Anemia in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Iron Deficiency Anemia in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Iron Deficiency Anemia in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Iron Deficiency Anemia in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Iron Deficiency Anemia in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Iron Deficiency Anemia in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Iron Deficiency Anemia in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Iron Deficiency Anemia in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Iron Deficiency Anemia in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Iron Deficiency Anemia in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Iron Deficiency Anemia in France (2016-2028) *
Figure 14: Diagnosed Cases of the Iron Deficiency Anemia in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Iron Deficiency Anemia in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Iron Deficiency Anemia in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Iron Deficiency Anemia in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Iron Deficiency Anemia in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Iron Deficiency Anemia in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Iron Deficiency Anemia in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Iron Deficiency Anemia in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Iron Deficiency Anemia in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Iron Deficiency Anemia in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Iron Deficiency Anemia in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Iron Deficiency Anemia in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Iron Deficiency Anemia in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Iron Deficiency Anemia in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Iron Deficiency Anemia in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Iron Deficiency Anemia in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Iron Deficiency Anemia in Japan (2016-2028)

  • Global Erythropoietin Stimulating Agents Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 113
    Market Overview of Global Erythropoietin Stimulating Agents market: According to our latest research, the global Erythropoietin Stimulating Agents market looks promising in the next 5 years. As of 2022, the global Erythropoietin Stimulating Agents market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Red blood cells are produced in the bone marrow (the spongy tissue inside the bone). In orde......
  • Global Erythropoietin Stimulating Agents Professional Survey Report 2023, Forecast to 2028
    Published: 13-Dec-2023        Price: US 3280 Onwards        Pages: 105
    Erythropoiesis-stimulating agent - Wikipediaen.wikipedia.org › wiki › Erythropoiesis-stimulating_a... Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market cap......
  • Global Erythropoietin Stimulating Agents Market Research Report 2023, Forecast to 2028
    Published: 13-Dec-2023        Price: US 2680 Onwards        Pages: 131
    Erythropoiesis-stimulating agent - Wikipediaen.wikipedia.org › wiki › Erythropoiesis-stimulating_a... Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market cap......
  • Global Erythropoietin Stimulating Agents Market Research Report 2023
    Published: 06-Dec-2023        Price: US 2900 Onwards        Pages: 92
    Erythropoiesis-stimulating agents (ESA) are medications which stimulate the bone marrow to make red blood cells. They are used to treat anemia due to end stage kidney disease, chemotherapy, major surgery, or certain treatments in HIV/AIDS. According to QYResearch's new survey, global Erythropoietin Stimulating Agents market is projected to reach US$ 12520 million in 2029, increasing from US$ 8939 million in 2022, with the CAGR of 4.2% during the period of 2023 to 2029. Key companie......
  • Global Erythropoietin Stimulating Agents Market Insights, Forecast to 2029
    Published: 02-Aug-2023        Price: US 4900 Onwards        Pages: 107
    Erythropoiesis-stimulating agents (ESA) are medications which stimulate the bone marrow to make red blood cells. They are used to treat anemia due to end stage kidney disease, chemotherapy, major surgery, or certain treatments in HIV/AIDS. Market Analysis and Insights: Global Erythropoietin Stimulating Agents Market The global Erythropoietin Stimulating Agents market is projected to grow from US$ 5779 million in 2023 to US$ 6244.6 million by 2029, at a Compound Annual Growth Rate (......
  • Global Erythropoietin Stimulating Agents Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 28-Feb-2023        Price: US 3260 Onwards        Pages: 128
    Erythropoietin is a hormone released the human renal system (kidney) which increases the rate of production of red blood cells in response to falling levels of oxygen in the tissues and helps in the process of erythropoiesis (production of red blood cells). Erythropoietin stimulating agents (EPO) are used to treat people undergone chemotherapy or treatments related to HIV. The Erythropoietin Stimulating Agents market revenue was XX Million USD in 2022, and will reach XX Million USD in 202......
  • Global Erythropoietin Stimulating Agents Market Research Report 2022 - Market Size, Current Insights and Development Trends
    Published: 01-Dec-2022        Price: US 3450 Onwards        Pages: 124
    Red blood cells are produced in the bone marrow (the spongy tissue inside the bone). In order to make red blood cells, the body maintains an adequate supply of erythropoietin (EPO), a hormone that is produced by the kidney. EPO helps make red blood cells. Having more red blood cells raises your hemoglobin levels. Hemoglobin is the protein in red blood cells that helps blood carry oxygen throughout the body. The report focuses on the Erythropoietin Stimulating Agents market size, s......
  • Global Erythropoietin Stimulating Agents Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 21-Nov-2022        Price: US 5600 Onwards        Pages: 106
    Report Scope This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Erythropoietin Stimulating Agents companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, ......
  • Global Erythropoietin Stimulating Agents Market Research Report 2022
    Published: 25-Jul-2022        Price: US 2900 Onwards        Pages: 91
    Erythropoietin Stimulating Agents market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Erythropoietin Stimulating Agents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Epoetin Alfa - Epoetin Beta - Darbepoetin ......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs